Mkp Capital Management, L.L.C. Novavax Inc Transaction History
Mkp Capital Management, L.L.C.
- $2.03 Billion
- Q4 2024
A detailed history of Mkp Capital Management, L.L.C. transactions in Novavax Inc stock. As of the latest transaction made, Mkp Capital Management, L.L.C. holds 25,000 shares of NVAX stock, worth $204,750. This represents 0.19% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$204,750% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
284Shares Held
95MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$126 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$97 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$91.3 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$63 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$48.6 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $641M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...